AK2 and lung adenocarcinoma: The immunohistochemical results in the 345 cases of lung adenocarcinoma revealed that expression of AK2 was significantly upregulated in tumors with the advanced stage, larger tumor size, lymph node metastasis, and acinar predominant subtype.